MYUNGMOON Pharm co.,Ltd (KRX: 017180)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,828.00
-20.00 (-1.08%)
Dec 20, 2024, 3:30 PM KST
-20.00%
Market Cap 61.11B
Revenue (ttm) 180.14B
Net Income (ttm) -7.57B
Shares Out 33.43M
EPS (ttm) -226.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 179,729
Open 1,843.00
Previous Close 1,848.00
Day's Range 1,788.00 - 1,875.00
52-Week Range 1,599.00 - 2,970.00
Beta 0.18
Analysts n/a
Price Target n/a
Earnings Date Mar 19, 2025

About MYUNGMOON Pharm co.,Ltd

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics,... [Read more]

Sector Healthcare
Founded 1983
Employees 282
Stock Exchange Korea Stock Exchange
Ticker Symbol 017180
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.